Clifford Chance offers a broad service offering which covers the full gamut of IP issues within the life sciences sector, including preliminary injunction applications and SPC-related mandates. Practice co-lead Miquel Montañá, who is praised by clients for his ‘curious legal mind’ and ’unmatched attention to detail’, is noted for his longstanding expertise in patent litigation within the life sciences sector, while fellow co-head Josep Montefusco is a key contact for unfair competition and advertising issues. Also jointly leading the team, Guillermo Guardia stands out for his experience in M&A and joint ventures, and Carme Briera often assists with public law issues within the health sector. Adrián Crespo regularly acts for pharma and biotech clients in major patent validity, revocation, and infringement disputes.
Testimonials
Collated independently by Legal 500 research team.
‘The patent litigation team around Miquel Montañá is clearly one of the very best Spain has to offer.’
‘Unmatched attention to detail. Miquel Montañá is a curious legal mind who likes to think outside the box and will do everything to win a case.’
Key clients
- Exact Sciences
- Illumina Cambridge
Work highlights
- Representing Pfizer in a case where Pfizer and Brystol Myers & Squibb successfully applied for and obtained a preliminary injunction application in relation to the patent that protects apixaban (Eliquis®), one of BMS' blockbusters, of which Pfizer is a co-promoter, in spite of the fact that Commercial Court number 4 of Barcelona had issued a fist instance judgment revoking the patent.
- Representing Edwards Lifesciences in patent infringement proceedings against an Indian competitor.